In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting organizations to seek innovative commercialization strategies for their drugs and devices. Additionally, the growing focus on patient-centricity and customer experience has accelerated outsourcing to specialized providers.
Providers are essential in this transformation. They offer expertise in generative AI, advanced analytics, and AI/ML, to streamline workflows and maximize efficiency. In response to market needs, they have expanded their portfolios to offer comprehensive, end-to-end solutions supporting pre-launch and post-launch commercialization activities.
-
Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025
In this report, we assess 30 providers featured on the Life Sciences AI and Analytics Commercial Services PEAK Matrix® Report. Each provider profile highlights the service focus, key IP/solutions, domain-specific investments, and case studies.
Scope
- Industry: life sciences
- Geography: global
- This assessment is based on Everest Group’s annual RFI process for calendar year 2024, interactions with leading commercial AI and analytics providers, client reference checks, and an ongoing analysis of the commercial AI and analytics market
Contents
This report analyzes 30 providers and includes:
- Their relative positioning on Everest Group’s Life Sciences AI and Analytics for Commercial Services PEAK Matrix®
- A comparison of their capabilities and market shares
- Their strengths and limitations
READ ON
What is the PEAK Matrix®?
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.
